ISRCTN ISRCTN16576123
DOI https://doi.org/10.1186/ISRCTN16576123
Protocol serial number NTR270
Sponsor Care and Public Health Research Institute (CAPHRI) (The Netherlands)
Funders VGZ Eindhoven (The Netherlands), CZ Health Insurance Company (CZ Actief in Gezondheid) (Netherlands)
Submission date
20/12/2005
Registration date
20/12/2005
Last edited
14/10/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Jody Martens
Scientific

Academic Hospital Maastricht
onderzoeker FTTO, BZe VII
P.O. Box 5800
Maastricht
6202 AZ
Netherlands

Phone +31 (0)43 387 7390/7388
Email jd.martens@caphri.unimaas.nl

Study information

Primary study designInterventional
Study designCluster randomised, single blind, active controlled, crossover trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesWe hypothesised that this strategy could lead to a considerable and relevant change of prescribing behaviour in the desired direction.
Ethics approval(s)Received from the local medical ethics committee
Health condition(s) or problem(s) studiedGP prescribing behaviour
InterventionA clustered RCT with incomplete block design was executed in the Maastricht and Eastern-South Limburg region.
Randomisation took place on practice level into two blocks: 25 GPs received reminders on antibiotics and asthma/chronic obstructive pulmonary disease (COPD) prescriptions, 28 GPs received reminders on cholesterol prescriptions. All GPs were told that they were participating in a trial, but they were blind for the fact that they only received part of the prescribing reminders.

A computer-reminder-system with reactive reminders was developed to lead to a change in prescribing behaviour in the desired direction. All relevant prescription was written to a special database. GPs were obliged to register a diagnosis for all patients with asthma/COPD, cholesterol related disease or infections for which antibiotics were prescribed. The diagnosis, anamnesis, prescription information as well as information about the patient and GP in question was written to this database.

The character of the reminders could be less or more persuasive and contained various types of reminders: alternative type of drugs, other doses, alternative drug administration, specific indication, other length of prescribing, not to prescribe anything or refer to specialist.

The guidelines on which the reminders were based were developed by multidisciplinary expert teams. The topics were selected because of high prevalence of the health problems and contained antibiotics, asthma/COPD related drugs and cholesterol lowering drugs.
Intervention typeOther
Primary outcome measure(s)

The central measure in our trial: prescription according to the guideline recommendation as a percentage of total prescriptions of that drug in block A and B.

Key secondary outcome measure(s)

Other measures are: absolute number of reminders per GP per year/ per total patient contacts per year in block A and B

Completion date01/10/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration53
Key inclusion criteriaOne inclusion criterion for inviting GPs to the intervention was using a specific medical information system for GPs called MicroHis.
Key exclusion criteriaDoes not comply with the above inclusion criteria
Date of first enrolment01/10/2003
Date of final enrolment01/10/2006

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Academic Hospital Maastricht
Maastricht
6202 AZ
Netherlands

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan